Literature DB >> 9445017

Correlated template-switching events during minus-strand DNA synthesis: a mechanism for high negative interference during retroviral recombination.

J A Anderson1, R J Teufel, P D Yin, W S Hu.   

Abstract

Two models for the mechanism of retroviral recombination have been proposed: forced copy choice (minus-strand recombination) and strand displacement-assimilation (plus-strand recombination). Each minus-strand recombination event results in one template switch, whereas each plus-strand recombination event results in two template switches. Recombinant proviruses with one and more than one template switches were previously observed. Recombinants with one template switch were generated by minus-strand recombination, while recombinants containing more than one template switch may have been generated by plus-strand recombination or by correlated minus-strand recombination. We recently observed that retroviral recombination exhibits high negative interference whereby the frequency of recombinants containing multiple template-switching events is higher than expected. To delineate the mechanism that generates recombinants with more than one template switch, we devised a system that permits only minus-strand recombination. Two highly homologous vectors, WH204 and WH221, containing eight different restriction site markers were used. The primer binding site (PBS) of WH221 was deleted; although reverse transcription cannot initiate from WH221 RNA, it can serve as a template for DNA synthesis in heterozygotic virions. After one round of retroviral replication, the structures of the recombinant proviruses were examined. Recombinants containing two, three, four, and five template switches were observed at 1.4-, 10-, 65-, and 50-fold-higher frequencies, respectively, than expected. This indicates that minus-strand recombination events are correlated and can generate proviruses with multiple template switches efficiently. The frequencies of recombinants containing multiple template switches were similar to those observed in the previous system, which allowed both minus- and plus-strand recombination. Thus, the previously reported high negative interference during retroviral recombination can be caused by correlated template switches during minus-strand DNA synthesis. In addition, all examined recombinants contained an intact PBS, indicating that most of the plus-strand DNA transfer occurs after completion of the strong-stop DNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445017      PMCID: PMC124595     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution.

Authors:  J J De Jong; A De Ronde; W Keulen; M Tersmette; J Goudsmit
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 2.  Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses.

Authors:  J M Coffin
Journal:  J Gen Virol       Date:  1979-01       Impact factor: 3.891

3.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.

Authors:  R E Phillips; S Rowland-Jones; D F Nixon; F M Gotch; J P Edwards; A O Ogunlesi; J G Elvin; J A Rothbard; C R Bangham; C R Rizza
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

4.  High rate of mismatch extension during reverse transcription in a single round of retrovirus replication.

Authors:  G A Pulsinelli; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

5.  Genetic recombinants and heterozygotes derived from endogenous and exogenous avian RNA tumor viruses.

Authors:  R A Weiss; W S Mason; P K Vogt
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Immunofluorescent studies of RD-114 virus replication in cell culture.

Authors:  J L Riggs; R M McAllister; E H Lennette
Journal:  J Gen Virol       Date:  1974-10       Impact factor: 3.891

7.  Retroviral DNA H structures: displacement-assimilation model of recombination.

Authors:  R P Junghans; L R Boone; A M Skalka
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

8.  E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy.

Authors:  J G Julias; D Hash; V K Pathak
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Possible involvement of cell fusion and viral recombination in generation of human immunodeficiency virus variants that display dual resistance to AZT and 3TC.

Authors:  Z Gu; Q Gao; E A Faust; M A Wainberg
Journal:  J Gen Virol       Date:  1995-10       Impact factor: 3.891

10.  In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies.

Authors:  H Jacobsen; M Hänggi; M Ott; I B Duncan; S Owen; M Andreoni; S Vella; J Mous
Journal:  J Infect Dis       Date:  1996-06       Impact factor: 5.226

View more
  26 in total

1.  Factors regulating template switch in vitro by viral RNA-dependent RNA polymerases: implications for RNA-RNA recombination.

Authors:  M J Kim; C Kao
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication.

Authors:  J K Pfeiffer; A Telesnitsky
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Pausing during reverse transcription increases the rate of retroviral recombination.

Authors:  Christian Lanciault; James J Champoux
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Aromatic residue mutations reveal direct correlation between HIV-1 nucleocapsid protein's nucleic acid chaperone activity and retroviral replication.

Authors:  Hao Wu; Mithun Mitra; Micah J McCauley; James A Thomas; Ioulia Rouzina; Karin Musier-Forsyth; Mark C Williams; Robert J Gorelick
Journal:  Virus Res       Date:  2012-07-16       Impact factor: 3.303

5.  High rate of recombination throughout the human immunodeficiency virus type 1 genome.

Authors:  A E Jetzt; H Yu; G J Klarmann; Y Ron; B D Preston; J P Dougherty
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events.

Authors:  Terence D Rhodes; Olga Nikolaitchik; Jianbo Chen; Douglas Powell; Wei-Shau Hu
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Retroviral recombination in vivo: viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239Deltavpx/Deltavpr and SIVmac239Deltanef.

Authors:  Eun-Young Kim; Marc Busch; Kristina Abel; Linda Fritts; Patty Bustamante; Jenny Stanton; Ding Lu; Samuel Wu; Jenny Glowczwskie; Tracy Rourke; Derek Bogdan; Mike Piatak; Jeffrey D Lifson; Ronald C Desrosiers; Steven Wolinsky; Christopher J Miller
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy.

Authors:  Jianling Zhuang; Sayandip Mukherjee; Yacov Ron; Joseph P Dougherty
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

9.  The M184V mutation in reverse transcriptase can delay reversion of attenuated variants of simian immunodeficiency virus.

Authors:  James B Whitney; Maureen Oliveira; Mervi Detorio; Yongjun Guan; Mark A Wainberg
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Frequent dual initiation in human immunodeficiency virus-based vectors containing two primer-binding sites: a quantitative in vivo assay for function of initiation complexes.

Authors:  Yegor A Voronin; Vinay K Pathak
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.